Syngene International Limited (SYNGENE.BO)
INR 627.85
(-0.83%)
INR 627.85
(-0.83%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.99 Billion INR | -62.57% |
| 2022 | 16.01 Billion INR | 21.05% |
| 2021 | 13.23 Billion INR | 12.63% |
| 2020 | 11.74 Billion INR | 20.38% |
| 2019 | 9.76 Billion INR | 20.67% |
| 2018 | 8.08 Billion INR | 20.02% |
| 2017 | 6.73 Billion INR | 16.85% |
| 2016 | 5.76 Billion INR | 21.62% |
| 2015 | 4.74 Billion INR | 22.23% |
| 2014 | 3.87 Billion INR | 28.51% |
| 2013 | 3.01 Billion INR | 22.77% |
| 2012 | 2.45 Billion INR | 21.13% |
| 2011 | 2.03 Billion INR | 16.07% |
| 2010 | 1.74 Billion INR | 14.99% |
| 2009 | 1.52 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.53 Billion INR | -4.43% |
| 2024 Q2 | 1.62 Billion INR | 6.01% |
| 2023 Q3 | 4.8 Billion INR | 1.01% |
| 2023 Q1 | 4.6 Billion INR | 28.96% |
| 2023 Q2 | 4.75 Billion INR | 3.37% |
| 2023 FY | 5.99 Billion INR | -62.57% |
| 2023 Q4 | 1.6 Billion INR | -66.63% |
| 2022 Q4 | 3.56 Billion INR | -16.6% |
| 2022 FY | 16.01 Billion INR | 21.05% |
| 2022 Q1 | 3.93 Billion INR | 19.48% |
| 2022 Q2 | 4.24 Billion INR | 7.88% |
| 2022 Q3 | 4.27 Billion INR | 0.83% |
| 2021 Q2 | 3.51 Billion INR | 8.28% |
| 2021 FY | 13.23 Billion INR | 12.63% |
| 2021 Q3 | 3.64 Billion INR | 3.52% |
| 2021 Q1 | 3.25 Billion INR | 28.1% |
| 2021 Q4 | 3.29 Billion INR | -9.66% |
| 2020 Q3 | 3.24 Billion INR | 4.07% |
| 2020 FY | 11.74 Billion INR | 20.38% |
| 2020 Q4 | 2.53 Billion INR | -21.82% |
| 2020 Q2 | 3.11 Billion INR | 15.4% |
| 2020 Q1 | 2.7 Billion INR | 43.42% |
| 2019 FY | 9.76 Billion INR | 20.67% |
| 2019 Q2 | 2.56 Billion INR | -5.22% |
| 2019 Q1 | 2.7 Billion INR | 80.74% |
| 2019 Q4 | 1.88 Billion INR | -34.63% |
| 2019 Q3 | 2.88 Billion INR | 12.53% |
| 2018 Q4 | 1.49 Billion INR | -34.2% |
| 2018 FY | 8.08 Billion INR | 20.02% |
| 2018 Q1 | 2.15 Billion INR | -1.78% |
| 2018 Q2 | 2.16 Billion INR | 0.42% |
| 2018 Q3 | 2.27 Billion INR | 4.94% |
| 2017 FY | 6.73 Billion INR | 16.85% |
| 2017 Q4 | 2.19 Billion INR | 7.23% |
| 2017 Q3 | 2.04 Billion INR | 22.21% |
| 2017 Q2 | 1.67 Billion INR | 6.21% |
| 2017 Q1 | 1.57 Billion INR | 11.69% |
| 2016 Q3 | 1.48 Billion INR | 1.36% |
| 2016 Q2 | 1.46 Billion INR | 4.12% |
| 2016 Q1 | 1.4 Billion INR | -6.19% |
| 2016 FY | 5.76 Billion INR | 21.62% |
| 2016 Q4 | 1.41 Billion INR | -5.04% |
| 2015 Q4 | 1.5 Billion INR | 29.82% |
| 2015 Q2 | 1.25 Billion INR | 17.26% |
| 2015 Q1 | 1.06 Billion INR | -3.27% |
| 2015 Q3 | 1.15 Billion INR | -7.44% |
| 2015 FY | 4.74 Billion INR | 22.23% |
| 2014 FY | 3.87 Billion INR | 28.51% |
| 2014 Q3 | 974 Million INR | 0.6% |
| 2014 Q2 | 968.2 Million INR | 8.32% |
| 2014 Q1 | 893.8 Million INR | 0.0% |
| 2014 Q4 | 1.1 Billion INR | 13.14% |
| 2013 FY | 3.01 Billion INR | 22.77% |
| 2012 FY | 2.45 Billion INR | 21.13% |
| 2011 FY | 2.03 Billion INR | 16.07% |
| 2010 FY | 1.74 Billion INR | 14.99% |
| 2009 FY | 1.52 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -483367.742% |
| Biocon Limited | 40.9 Billion INR | 85.343% |
| Blue Jet Healthcare Limited | 531.85 Million INR | -1027.198% |
| Concord Biotech Limited | 1.45 Billion INR | -310.7% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | -16.467% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | -694.873% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -1598566.667% |
| Lyka Labs Limited | 599.4 Million INR | -900.155% |
| Panacea Biotec Limited | 1.99 Billion INR | -200.441% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -400265.973% |
| Servoteach Industries Limited | 785.00 INR | -763694167.516% |
| SMS Lifesciences India Limited | 602.96 Million INR | -894.25% |
| Supriya Lifescience Limited | 1.08 Billion INR | -455.016% |
| TAKE Solutions Limited | 396.91 Million INR | -1410.418% |
| Titan Biotech Limited | 117.05 Million INR | -5021.437% |
| Transgene Biotek Limited | 5.39 Million INR | -110980.23% |
| Vanta Bioscience Limited | 38.95 Million INR | -15288.367% |